|
Aug 17
|
MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline
|
|
Aug 7
|
MannKind Second Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.007 loss in 2Q 2024)
|
|
Aug 6
|
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Aug 6
|
MannKind (MNKD) Reports Break-Even Earnings for Q2
|
|
Aug 6
|
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
|
|
Aug 6
|
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
|
|
Aug 1
|
H.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product Pipeline
|
|
Jul 31
|
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 30
|
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
|
|
Jul 30
|
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 28
|
RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating
|
|
Jul 23
|
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association
|
|
Jul 17
|
Nontuberculous Mycobacteria (NTM) Opportunity Assessment and Forecast to 2033 Featuring Janssen, Novartis, Meiji Seika Pharma, Insmed, Daiichi Sankyo, MannKind, Paratek, Nobelpharma, GSK, Pfizer
|
|
Jul 14
|
High Growth Tech Stocks To Watch In The US July 2025
|
|
Jul 11
|
Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT
|
|
Jun 25
|
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
|
|
Jun 24
|
Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating
|
|
Jun 9
|
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
|
|
Mar 10
|
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
|
|
Mar 1
|
MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
|